PAHC Phibro Animal Health Corp

Price (delayed)

$35.02

Market cap

$1.42B

P/E Ratio

13.79

Dividend/share

$0.48

EPS

$2.54

Enterprise value

$2.08B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 72

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who ...

Highlights
PAHC's P/E is 62% below its 5-year quarterly average of 36.0 and 17% below its last 4 quarters average of 16.7
PAHC's EPS has surged by 52% year-on-year and by 3.3% since the previous quarter
The quick ratio has decreased by 8% YoY

Key stats

What are the main financial stats of PAHC

PAHC stock price

How has the Phibro Animal Health stock price performed over time
Intraday
-2.64%
1 week
1.18%
1 month
-9.79%
1 year
-22.35%
YTD
-6.26%
QTD
-2.01%

Financial performance

How have Phibro Animal Health's revenue and profit performed over time
Revenue
$1.54B
Gross profit
$521.27M
Operating income
$192.78M
Net income
$102.71M
Gross margin
33.8%
Net margin
6.7%
PAHC's net income has surged by 51% year-on-year and by 3% since the previous quarter
PAHC's net margin is up by 40% YoY
PAHC's operating income is up by 34% year-on-year
The operating margin rose by 21% year-on-year but it has declined by 2.3% since the previous quarter

Price vs fundamentals

How does PAHC's price correlate with its fundamentals

Growth

What is Phibro Animal Health's growth rate over time

Valuation

What is Phibro Animal Health stock price valuation
P/E
13.79
P/B
3.4
P/S
0.92
EV/EBIT
11.34
EV/EBITDA
8.83
EV/Sales
1.35
PAHC's P/E is 62% below its 5-year quarterly average of 36.0 and 17% below its last 4 quarters average of 16.7
PAHC's EPS has surged by 52% year-on-year and by 3.3% since the previous quarter
The equity is up by 34% year-on-year and by 8% since the previous quarter
PAHC's P/B is 23% below its last 4 quarters average of 4.4 but 10% above its 5-year quarterly average of 3.1
The stock's price to sales (P/S) is 16% less than its last 4 quarters average of 1.1 but 15% more than its 5-year quarterly average of 0.8
The revenue has increased by 10% year-on-year

Efficiency

How efficient is Phibro Animal Health business performance
Phibro Animal Health's ROA has increased by 37% YoY
The ROIC has increased by 30% YoY
PAHC's return on sales is up by 25% year-on-year
The return on equity is up by 12% year-on-year but it has declined by 4.5% since the previous quarter

Dividends

What is PAHC's dividend history
DPS
$0.48
Dividend yield
1.37%
Payout ratio
18.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 38% higher than its total liabilities
Phibro Animal Health's total assets has increased by 9% YoY
Phibro Animal Health's current ratio has increased by 8% QoQ and by 3.6% YoY
PAHC's debt is 76% higher than its equity
The equity is up by 34% year-on-year and by 8% since the previous quarter
PAHC's debt to equity is down by 26% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.